IDH1 and central nervous system cancer: Unbiased metabolomics flux experiments using a panel of isogenic cell lines containing heterozygous IDH1/2 mutations revealed elevated glucose turnover in IDH-wt glioma cells and increased dependence on mitochondrial oxidative phosphorylation (OxPhos) in IDH-mutant cells [19].